SG152296A1 - Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2- one - Google Patents

Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2- one

Info

Publication number
SG152296A1
SG152296A1 SG200903039-6A SG2009030396A SG152296A1 SG 152296 A1 SG152296 A1 SG 152296A1 SG 2009030396 A SG2009030396 A SG 2009030396A SG 152296 A1 SG152296 A1 SG 152296A1
Authority
SG
Singapore
Prior art keywords
thiazolo
pyrimidin
amino
preparation
novel process
Prior art date
Application number
SG200903039-6A
Other languages
English (en)
Inventor
Tingman Wang
John S Ng
Stephen E Webber
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Publication of SG152296A1 publication Critical patent/SG152296A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
SG200903039-6A 2005-11-21 2006-11-20 Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2- one SG152296A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73805505P 2005-11-21 2005-11-21

Publications (1)

Publication Number Publication Date
SG152296A1 true SG152296A1 (en) 2009-05-29

Family

ID=37908057

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200903039-6A SG152296A1 (en) 2005-11-21 2006-11-20 Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2- one

Country Status (18)

Country Link
US (1) US7781581B2 (zh)
EP (1) EP1973920B1 (zh)
JP (1) JP5117391B2 (zh)
KR (1) KR20080090400A (zh)
CN (1) CN101365705A (zh)
AR (1) AR058210A1 (zh)
AT (1) ATE474842T1 (zh)
AU (1) AU2006318260B2 (zh)
BR (1) BRPI0618789A2 (zh)
CA (1) CA2630463C (zh)
DE (1) DE602006015700D1 (zh)
EA (1) EA200801404A1 (zh)
ES (1) ES2345904T3 (zh)
IL (1) IL191568A0 (zh)
NO (1) NO20082365L (zh)
SG (1) SG152296A1 (zh)
TW (1) TWI383987B (zh)
WO (1) WO2007062355A2 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5345527B2 (ja) 2006-06-22 2013-11-20 アナディス ファーマシューティカルズ インク プロドラッグである5−アミノ−3−(3’−デオキシ−β−D−リボフラノシル)−チアゾロ[4,5−d]ピリミジン−2,7−ジオン
JPWO2012102366A1 (ja) * 2011-01-28 2014-06-30 日本たばこ産業株式会社 新規ピペラジン化合物の製造方法
CN103012284A (zh) * 2012-12-26 2013-04-03 无锡捷化医药科技有限公司 一种2-氨基-5-溴嘧啶类化合物的制备方法
CA2963717C (en) 2014-12-08 2023-10-10 F. Hoffmann-La Roche Ag 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
CA3048768A1 (en) 2017-01-06 2018-07-12 F. Hoffmann-La Roche Ag Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds
CN111635368B (zh) * 2020-06-12 2021-06-29 东莞市东阳光仿制药研发有限公司 一种胺化合物的制备方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539205A (en) 1982-11-09 1985-09-03 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4643992A (en) 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5166141A (en) 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
US4746651A (en) 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives
US5011828A (en) 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
GB8712745D0 (en) 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
US4880784A (en) 1987-12-21 1989-11-14 Brigham Young University Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
US5041426A (en) 1987-12-21 1991-08-20 Brigham Young University Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides
US5041542A (en) 1988-06-03 1991-08-20 Nucleic Acid Research Institute Substituted pyrimido[5,4-d]pyrimidine nucleosides
GB9015914D0 (en) 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
GB9105899D0 (en) 1991-03-20 1991-05-08 Wellcome Found Therapeutic nucleosides
AU5165793A (en) 1992-10-01 1994-04-26 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
GB9301000D0 (en) 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
US5395937A (en) 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5446045A (en) 1993-12-20 1995-08-29 Revankar; Ganapathi R. Antiviral guanine analogs
US5994321A (en) 1993-12-20 1999-11-30 Aronex Pharmaceuticals, Inc. Antiviral guanine analogs
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
AU698419B2 (en) 1996-07-03 1998-10-29 Dainippon Sumitomo Pharma Co., Ltd. A novel purine derivative
CZ126799A3 (cs) 1996-10-16 1999-07-14 Icn Pharmaceuticals Purinové L-nukleosidy a jejich analogy a farmaceutické prostředky, které je obsahují
US6509320B1 (en) 1996-10-16 2003-01-21 Icn Pharmaceuticals, Inc. Purine L-nucleosides, analogs and uses thereof
EP0938315B9 (en) 1996-10-25 2008-02-20 Minnesota Mining And Manufacturing Company Immune response modifier compounds for treatment of th2 mediated and related diseases
NZ504800A (en) 1997-11-28 2001-10-26 Sumitomo Pharma 6-Amino-9-benzyl-8-hydroxy-purine derivatives and interferon inducers, antiviral agents, anticancer agents and therapeutic agents for immunologic diseases thereof
TW572758B (en) 1997-12-22 2004-01-21 Sumitomo Pharma Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
JP2002510695A (ja) * 1998-04-03 2002-04-09 デュポン ファーマシューティカルズ カンパニー 副腎皮質刺激ホルモン放出因子(CRF)拮抗剤としてのチアゾロ[4,5−d]ピリミジンおよびピリジン
US6444652B1 (en) 1998-08-10 2002-09-03 Novirio Pharmaceuticals Limited β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
US6664260B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Heterocyclic ether substituted imidazoquinolines
US6545017B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Urea substituted imidazopyridines
US6664264B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6545016B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Amide substituted imidazopyridines
US6667312B2 (en) 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines
US20020086871A1 (en) 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders
JP4331944B2 (ja) 2001-04-17 2009-09-16 大日本住友製薬株式会社 新規アデニン誘導体
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
KR100718371B1 (ko) 2001-11-27 2007-05-14 애나디스 파마슈티칼스, 인코포레이티드 3-β-D-리보푸라노실티아졸로[4,5-d]피리디민누클레오시드 및 이의 용도
CA2484921A1 (en) 2002-05-06 2003-11-13 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis c virus infection
US7196090B2 (en) * 2002-07-25 2007-03-27 Warner-Lambert Company Kinase inhibitors
US20050004144A1 (en) 2003-04-14 2005-01-06 Regents Of The University Of California Combined use of IMPDH inhibitors with toll-like receptor agonists
KR20060027338A (ko) * 2003-06-12 2006-03-27 아스텔라스세이야쿠 가부시키가이샤 벤즈 아미드 유도체 또는 그 염
EA200600540A1 (ru) 2003-09-05 2006-08-25 Анадис Фармасьютикалз, Инк. Введение лигандов tlr7 и их пролекарств для лечения инфекции вируса гепатита с
JP2007527918A (ja) * 2004-03-08 2007-10-04 アムジェン インコーポレイテッド Pparガンマ活性の治療的調節
BRPI0516483A (pt) 2004-10-15 2008-09-02 Bayer Pharmaceuticals Corp preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade
PL2561872T3 (pl) * 2004-12-17 2015-03-31 Anadys Pharmaceuticals Inc 3,5-Dipodstawione oraz 3,5,7-tripodstawione związki 3H-oksazolo[4,5-d]pirymidyn-2-onowe i ich proleki
TWI401254B (zh) 2005-05-09 2013-07-11 Hydra Biosciences Inc 用於調節trpv3功能之化合物
JP5345527B2 (ja) 2006-06-22 2013-11-20 アナディス ファーマシューティカルズ インク プロドラッグである5−アミノ−3−(3’−デオキシ−β−D−リボフラノシル)−チアゾロ[4,5−d]ピリミジン−2,7−ジオン
EP2040712B1 (en) 2006-07-18 2011-03-02 Anadys Pharmaceuticals, Inc. Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines

Also Published As

Publication number Publication date
WO2007062355A3 (en) 2007-07-26
EA200801404A1 (ru) 2008-10-30
JP5117391B2 (ja) 2013-01-16
WO2007062355A2 (en) 2007-05-31
CN101365705A (zh) 2009-02-11
KR20080090400A (ko) 2008-10-08
AU2006318260A1 (en) 2007-05-31
IL191568A0 (en) 2008-12-29
ATE474842T1 (de) 2010-08-15
US20070117979A1 (en) 2007-05-24
ES2345904T3 (es) 2010-10-05
NO20082365L (no) 2008-08-18
JP2009516709A (ja) 2009-04-23
CA2630463A1 (en) 2007-05-31
CA2630463C (en) 2015-01-06
AR058210A1 (es) 2008-01-23
TW200736265A (en) 2007-10-01
AU2006318260B2 (en) 2012-05-17
US7781581B2 (en) 2010-08-24
EP1973920B1 (en) 2010-07-21
TWI383987B (zh) 2013-02-01
BRPI0618789A2 (pt) 2016-08-30
EP1973920A2 (en) 2008-10-01
DE602006015700D1 (de) 2010-09-02

Similar Documents

Publication Publication Date Title
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
TW200716589A (en) Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole
TW200640926A (en) Pyrazolopyrimidines
ZA200708187B (en) Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-D]pyrimidine derivatives
ZA200605865B (en) Methods for the preparation of fine chemical by fermentation
TW200745137A (en) Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
UA93517C2 (en) Amorphous solid dispersion formulations comprising 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazino[4,5-b]indole-1-acetamide
HK1122743A1 (en) Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin- related compounds and a disaccharide for treating proliferative diseases
TNSN07440A1 (en) Derivatives of pyrido [2,3 -d] pyrimidine, the preparation thereof, and the therapeutic application of the same
DK1742950T3 (da) Pyrazolo-[4,3-D]-pyrimidiner
SG152296A1 (en) Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2- one
ZA200402695B (en) Process for the preparation of methanol.
MX2008011576A (es) Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.
PT2185561E (pt) Derivados de 1,2,3,4-tetra-hidropirrolo(1,2-a)pirazina-6- carboxamidas e de 2,3,4,5-tetra-hidropirrolo(1,2-a)-diazepina-7- carboxamidas, sua preparação e sua aplicação em terapia
WO2008099416A3 (en) Novel benzothiazole and benzoxazole linked pyrrolo[2,1-c] [1, 4] benzodiazepine hybrids as novel antitumour agents and process for the preparation thereof
IL187441A0 (en) Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid
HUP0600231A2 (en) Novel process for the preparation of 2h-chromenes
TW200510323A (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
IL176471A0 (en) Process for the preparation of triazolopyrimidines
HUP0500940A2 (en) Process for the preparation of carbidopa
TW200732342A (en) Process for the preparation of purified crystalline CCI-779
IL186457A0 (en) Process for the preparation of 9,10-dehydro-12,13-desoxyepothilone derivatives
GB2434795A (en) Pyrrolo [2, 1-C] [1, 4] benzodiazepine-anthraquinone conjugates useful as antitumour agents
AU2003269482A1 (en) Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde
AU2003272080A1 (en) Novel process for the preparation of tert-butyl 6-cyano-5-hydroxy-3-oxohexanoate